Literature DB >> 7570061

Metastatic colorectal cancer: advances in biochemical modulation and new drug development.

N J Meropol1, P J Creaven, N J Petrelli.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7570061

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  5 in total

Review 1.  Capecitabine.

Authors:  D R Budman
Journal:  Invest New Drugs       Date:  2000-11       Impact factor: 3.850

Review 2.  Novel oral chemotherapy agents.

Authors:  M E Royce; P M Hoff; R Pazdur
Journal:  Curr Oncol Rep       Date:  2000-01       Impact factor: 5.075

Review 3.  A review of the pharmacology and clinical activity of new chemotherapy agents for the treatment of colorectal cancer.

Authors:  A A Adjei
Journal:  Br J Clin Pharmacol       Date:  1999-09       Impact factor: 4.335

4.  A phase II study of high-dose 24 hour continuous infusion 5-FU and leucovorin and low-dose PALA for patients with advanced pancreatic adenocarcinoma: a Southwest Oncology Group Study.

Authors:  Robert P Whitehead; Jacqueline K Benedetti; James L Abbruzzese; Bach Ardalan; J Wendall Goodwin; Stanley P Balcerzak; Wolfram E Samlowski; Heinz-Josef Lenz; John S Macdonald
Journal:  Invest New Drugs       Date:  2004-08       Impact factor: 3.850

5.  Antiproliferative effect of immunoliposomes containing 5-fluorodeoxyuridine-dipalmitate on colon cancer cells.

Authors:  G A Koning; A Gorter; G L Scherphof; J A Kamps
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.